21 – 30 of 76
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2017
- 
                        Mark
        Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
    
    - Contribution to journal › Article
 
- 2016
- 
                        Mark
        Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
    
    - Contribution to journal › Article
 
- 
                        Mark
        PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia
    
    - Contribution to journal › Article
 
- 2015
- 
                        Mark
        Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia
    
    - Contribution to journal › Article
 
- 
                        Mark
        The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells
    
    - Contribution to journal › Letter
 
- 
                        Mark
        Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase 2 study by The Nordic Lymphoma Group.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease
    
    - Contribution to journal › Letter
 
- 
                        Mark
        Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
    
    - Contribution to journal › Letter
 
- 
                        Mark
        Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.
    
    - Contribution to journal › Article
 
